IntraBio Gets EU Approval for AQNEURSA® in Niemann-Pick C
IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) disease,...